Hip Osteoarthritis – A Complete Medical Guide

Overview

Hip osteoarthritis (OA) is a degenerative joint disease characterized by the breakdown of cartilage that cushions the head of the femur (thigh bone) and the acetabulum (hip socket). As the cartilage wears away, the bones can rub together, causing pain, stiffness, and reduced range of motion.

OA is the most common form of arthritis, and the hip is the second‑most frequently affected joint after the knee. In the United States, an estimated 10 % of adults over age 45 have symptomatic hip OA, and prevalence rises to >30 % in people older than 75 years.^CDC Women are slightly more likely than men to develop hip OA, and the condition is more common in people with a family history of arthritis.

Symptoms

Symptoms often develop slowly and may be mild at first. Common complaints include:

• Hip pain – aching or sharp pain in the groin, buttock, thigh, or outside of the hip. Pain may worsen with prolonged standing, walking, or climbing stairs.
• Stiffness – especially after periods of inactivity (e.g., first thing in the morning or after sitting).
• Reduced range of motion – difficulty rotating the leg, putting on shoes, or getting in and out of a car.
• Joint grinding or clicking (crepitus) – a sensation of bone‑on‑bone contact.
• Muscle weakness – particularly in the gluteal muscles, due to pain‑related disuse.
• Altered gait – limping or “Trendelenburg gait” where the pelvis drops on the opposite side during walking.
• Pain at night – can disturb sleep if the joint is inflamed.

Symptoms may be intermittent early on, becoming more constant as the disease progresses.

Causes and Risk Factors

Primary (idiopathic) OA

The exact cause is unknown, but it involves a combination of mechanical stress, biochemical changes, and genetic factors that lead to cartilage degeneration.

Secondary OA

OA that results from another condition, such as:

• Hip dysplasia or developmental malformations.
• Leg length discrepancy.
• Previous hip fracture or surgical trauma.
• Inflammatory arthritis (e.g., rheumatoid arthritis).

Major Risk Factors

• Age – risk rises sharply after age 45.
• Sex – women have a slightly higher risk, especially after menopause.
• Genetics – having a first‑degree relative with OA roughly doubles the risk.^NIH
• Obesity – each 5‑unit increase in BMI raises hip OA risk by about 20 %.
• Joint injury – sports‑related or occupational injuries accelerate cartilage wear.
• Occupational stress – jobs requiring heavy lifting, prolonged standing, or repetitive hip flexion.
• Bone shape – certain femoral head or acetabular geometries increase contact stress.

Diagnosis

Diagnosis combines a clinical assessment with imaging and, occasionally, laboratory studies.

Clinical Evaluation

• Detailed history (onset, pattern, aggravating/relieving factors).
• Physical exam: gait analysis, assessment of hip range of motion, palpation for tenderness, and special tests (e.g., FABER test).

Imaging Studies

• Plain radiographs (X‑ray) – first‑line; looks for joint space narrowing, osteophytes, subchondral sclerosis, and cysts. The Kellgren‑Lawrence grading system is commonly used.
• MRI – useful when X‑ray is inconclusive or when ruling out other intra‑articular pathologies (labral tears, avascular necrosis).
• CT scan – may help assess bone morphology before surgical planning.

Laboratory Tests

Blood tests are not diagnostic for OA but are performed to exclude inflammatory arthritis (e.g., rheumatoid factor, anti‑CCP, ESR, CRP). Joint aspiration is rarely needed unless infection or crystal arthropathy is suspected.

Treatment Options

Management is individualized, emphasizing symptom relief, functional improvement, and slowing disease progression.

Non‑pharmacologic Strategies

• Exercise – low‑impact activities (walking, swimming, stationary cycling) improve muscle strength and joint stability.
• Physical therapy – tailored programs focusing on hip abductors, extensors, and core stability.
• Weight management – losing 5–10 % of body weight can reduce hip joint load by 10 %.
• Assistive devices – cane or walker to off‑load the affected hip.
• Joint protection – ergonomic modifications at work and home.

Pharmacologic Treatment

Medication	Typical Dose	Key Benefits	Important cautions
Acetaminophen	Up to 3 g/day	Pain relief with minimal GI risk	Liver toxicity at high doses; avoid with chronic alcohol use
NSAIDs (ibuprofen, naproxen, diclofenac)	Ibuprofen 400–800 mg q6h	Reduces pain & inflammation	GI ulcer, renal impairment, cardiovascular risk—use lowest effective dose
Topical NSAIDs (diclofenac gel)	Apply 2–4 g to hip 3–4×/day	Effective for mild–moderate pain with fewer systemic side effects	Skin irritation possible
Intra‑articular corticosteroid injection	Triamcinolone 40 mg	Provides short‑term pain relief (up to 12 weeks)	Repeated use can accelerate cartilage loss; limit to ≤4 injections/year
Viscosupplementation (hyaluronic acid)	One‑time or series of injections	May improve lubrication; evidence modest	Cost and limited insurance coverage

Surgical Options

• Total Hip Arthroplasty (THA) – replacement of the femoral head and acetabulum; indicated for severe pain limiting daily activities despite optimal conservative care. 5‑year survivorship exceeds 95 % in modern prostheses.^{Cleveland Clinic}
• Hip resurfacing – bone‑preserving alternative for younger, active patients with good bone stock.
• Osteotomy – realignment surgery for select cases with abnormal hip geometry.

Living with Hip Osteoarthritis

Daily Management Tips

• Start the day with gentle stretching (hip flexor, piriformis, gluteal stretches).
• Incorporate strengthening 3×/week (e.g., side‑lying clamshells, bridges, resisted hip abduction).
• Use a supportive mattress and a firm chair with adequate lumbar support.
• Apply heat before activity to relax muscles; consider ice after activity if swelling occurs.
• Plan rest periods during prolonged standing or walking; use a cane on the opposite side of the painful hip for short walks.
• Maintain a balanced diet rich in omega‑3 fatty acids, vitamin D, and calcium to support bone health.
• Monitor pain levels with a simple diary; share trends with your healthcare provider for medication adjustments.

Psychosocial Considerations

Chronic pain can affect mood and sleep. Cognitive‑behavioral therapy (CBT), support groups, or counseling can help manage depressive symptoms and improve coping strategies.^{Mayo Clinic}

Prevention

While aging cannot be stopped, several measures can lower the risk of developing hip OA or slow its progress:

• Maintain a healthy weight – aim for BMI 18.5–24.9.
• Engage in regular, low‑impact aerobic activity – at least 150 minutes per week.
• Strengthen hip stabilizers – especially the gluteus medius and maximus.
• Protect joints during sports – use proper technique and avoid high‑impact activities if you already have joint pain.
• Early treatment of joint injuries – appropriate rehab after sprains, fractures, or dislocations.
• Screen and manage underlying conditions – e.g., diabetes, metabolic syndrome, which may affect cartilage health.

Complications

If left untreated or poorly managed, hip OA can lead to:

• Severe, persistent pain that limits basic activities (bathing, dressing).
• Progressive loss of joint function and fixed deformities.
• Secondary osteonecrosis due to altered biomechanics.
• Increased risk of falls and hip fractures because of weakness and gait instability.
• Depression, social isolation, and reduced quality of life.

When to Seek Emergency Care

For non‑urgent concerns, schedule an appointment with your primary care physician or a rheumatologist/orthopedic specialist.

References

1. Centers for Disease Control and Prevention. Arthritis Data & Statistics. https://www.cdc.gov/arthritis/data_statistics.htm
2. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS). Osteoarthritis. https://www.niams.nih.gov/health-topics/osteoarthritis
3. Mayo Clinic. Hip osteoarthritis – symptoms and causes. https://www.mayoclinic.org/
4. Cleveland Clinic. Total Hip Replacement. https://my.clevelandclinic.org/
5. World Health Organization. Musculoskeletal conditions. https://www.who.int/